Biospective

Biospective provides industry-leading preclinical neuroscience CRO services using validated rodent models of neurodegenerative diseases. Their expertise includes dosing, behavioral testing, electrophysiology, biomarker analysis, histology/tissue analysis, advanced imaging technologies (MRI/PET/CT/SPECT), image processing/analysis for both preclinical studies and clinical trials. They serve as a full-service neuroimaging core lab supporting early through late-phase CNS clinical trials with quantitative imaging biomarkers. No internal drug development or direct clinical results reported—services enable client programs across the spectrum of neurological disorders.